Back to Zürcher Kantonalbank Zürcher Kantonalbank

TNGX

Showing 8 of 14 quarters

Position history for Zürcher KantonalbankZürcher Kantonalbank's holdings in Tango Therapeutics, Inc.

Yes. Zürcher Kantonalbank holds 27,974 shares of TNGX (Tango Therapeutics), worth $874,467, as of its Q2 2026 13F filing. It increased the position by 17,327 shares (+162.7%) from Q1 2026. Zürcher Kantonalbank has held TNGX since Q1 2023, across 14 quarterly 13F filings.

Current Value

$874,467

Current Shares

27,974

Total Value Change

+$768,007

Total Shares Change

+14,148

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
27,974
+162.7%
$874,4670.0%$31.26
40
2026-Q1
Increased
10,647
+138.3%
$222,7350.0%$20.92
37
2025-Q4
Increased
4,467
+1488x
$39,5780.0%$8.86
32
2025-Q3
Unchanged
3
0.0%
$250.0%$8.40
0
2025-Q2
Unchanged
3
0.0%
$150.0%$5.12
0
2025-Q1
Decreased
3
-100.0%
$40.0%$1.37
0
2024-Q4
Decreased
13,494
-2.4%
$41,6960.0%$3.09
0
2024-Q3
Unchanged
13,826
0.0%
$106,4600.0%$7.47
0

Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used